Flynn James E 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:11 pm Sale |
2021-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
Flynn James E | 958,125 3.470% |
-1,594,662 (-62.47%) |
Filing |
| 2021-05-04 12:33 pm Purchase |
2021-05-04 | 13G | Werewolf Therapeutics, Inc. HOWL |
Flynn James E | 2,552,787 9.270% |
2,552,787 (New Position) |
Filing |